Prothena Corp Public (PRTA) Interest Coverage Ratio (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Interest Coverage Ratio came in at 37.54 in Q1 2026, up 140.07% year-on-year from 15.64 in Q1 2025, and up 224.1% quarter-over-quarter from 30.25 in Q4 2025.
Prothena Corp Public (PRTA) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Prothena Corp Public's Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 37.54 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 140.07% year-over-year to 37.54 in Q1 2026; TTM through Mar 2026 was 38.39, a 22.44% increase from a year earlier, with the FY2025 full-year figure at 0.81, down 3.6% from the prior year.
- Interest Coverage Ratio improved to 37.54 in Q1 2026 per PRTA's latest filing, from 30.25 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 83.4 in Q2 2024 and bottomed at 163.06 in Q1 2024.
- The 5-year median for Interest Coverage Ratio is 30.25 (2025), against an average of 32.18.
- Across the five-year window, Interest Coverage Ratio surged 38872.84% in 2023 and sank 1574.87% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.04 in 2022, then jumped by 38872.84% to 17.45 in 2023, then sank by 631.36% to 92.71 in 2024, then surged by 67.37% to 30.25 in 2025, then jumped by 224.1% to 37.54 in 2026.
- Per Business Quant, the three latest PRTA Interest Coverage Ratio figures stand at 37.54 (Q1 2026), 30.25 (Q4 2025), and 50.3 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 37.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.54 |
| Dec 31, 2025 | -30.25 |
| Sep 30, 2025 | -50.30 |
| Jun 30, 2025 | -7.86 |
| Mar 31, 2025 | -93.69 |
| Dec 31, 2024 | -92.71 |
| Sep 30, 2024 | -95.02 |
| Jun 30, 2024 | 83.40 |
| Mar 31, 2024 | -163.06 |
| Dec 31, 2023 | 17.45 |
| Sep 30, 2023 | 6.44 |
| Jun 30, 2023 | -41.57 |
| Mar 31, 2023 | -35.20 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | -31.46 |
| Jun 30, 2022 | -27.01 |
| Mar 31, 2022 | -23.72 |
| Dec 31, 2021 | -20.68 |
| Sep 30, 2021 | 72.82 |
| Jun 30, 2021 | 18.63 |